|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61P 3/10 | |||
| A61K 31/713 |
| (11) | Number of the document | 3011026 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14813708.6 |
| Date of filing the European patent application | 2014-06-23 | |
| (97) | Date of publication of the European application | 2016-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/043723 |
| Date | 2014-06-23 |
| (87) | Number | WO 2014/205449 |
| Date | 2014-12-24 |
| (30) | Number | Date | Country code |
| 201361838211 P | 2013-06-21 | US |
| (72) |
CROOKE, Rosanne, M., US
ALEXANDER, Veronica, J., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | COMPOUNDS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION FOR IMPROVING A DIABETIC PROFILE |
| COMPOUNDS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION FOR IMPROVING A DIABETIC PROFILE |